Your browser doesn't support javascript.
loading
Susceptibility testing for aztreonam plus ceftazidime/avibactam combination: A general guidance for clinical microbiology laboratories in India
Indian J Med Microbiol ; 2022 Mar; 40(1): 3-6
Article | IMSEAR | ID: sea-222831
ABSTRACT
Metallo beta-lactamases-producing Gram-negative infection is often challenging and there is no defined treatment option. In recent years, the combination of aztreonam with ceftazidime-avibactam has gained much clinical attention mainly for MBL-producing Enterobacterales, while MBL-producing P. aeruginosa and A. baumannii are likely to be resistant. A consensus susceptibility testing method for this triple combination has yet to be recommended. Various methods such as broth disk elution, disk stacking, gradient strip stacking, and strip crossing have been proposed for testing this combination. Among them, broth disk elution and strip based testing methods showed good correlation with the broth micro-dilution method.

Texte intégral: Disponible Indice: IMSEAR (Asie du Sud-Est) Texte intégral: Indian J Med Microbiol Thème du journal: Microbiology Année: 2022 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: IMSEAR (Asie du Sud-Est) Texte intégral: Indian J Med Microbiol Thème du journal: Microbiology Année: 2022 Type: Article